Literature DB >> 12865418

Critical role of IL-10 in the induction of low zone tolerance to contact allergens.

Marcus Maurer1, Wolfgang Seidel-Guyenot, Martin Metz, Juergen Knop, Kerstin Steinbrink.   

Abstract

The development and mechanisms of tolerance to allergens are poorly understood. Using the murine low zone tolerance (LZT) model, where contact hypersensitivity (CHS) is prevented by repeated topical low-dose applications of contact allergens, we show that LZT induction is IL-10 dependent. IL-10 is required for the generation of LZT effector cells, that is, CD8+ regulatory T cells. Only T cells from tolerized IL-10+/+ mice or IL-10-/- mice reconstituted with IL-10 during LZT induction adoptively transferred LZT to naive mice and prevented CHS, whereas T cells from IL-10-/- mice failed to do so. The IL-10 required for normal LZT development is derived from lymph node CD4+ T cells, the only skin or lymph node cell population found to produce relevant amounts of IL-10 after tolerization. CD4+ T cells derived from IL-10+/+ mice, but not from IL-10-/- mice, allowed the induction of LZT in adoptively transferred T cell-deficient mice. Interestingly, IL-10 injections during tolerization greatly enhanced LZT responses in normal mice. Thus, the generation of CD8+ LZT effector T cells by CD4+ regulatory T cells via IL-10 may be a promising target of strategies aimed at preventing contact allergies and other harmful immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12865418      PMCID: PMC166297          DOI: 10.1172/JCI18106

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

Review 1.  Immune responses to dietary antigens: oral tolerance.

Authors:  S Strobel; A M Mowat
Journal:  Immunol Today       Date:  1998-04

2.  CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.

Authors:  E Suri-Payer; A Z Amar; A M Thornton; E M Shevach
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

3.  Induction of low zone tolerance to contact allergens in mice does not require functional Langerhans cells.

Authors:  K Steinbrink; G Kolde; C Sorg; E Macher
Journal:  J Invest Dermatol       Date:  1996-08       Impact factor: 8.551

4.  Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice.

Authors:  S Beissert; J Hosoi; R Kühn; K Rajewsky; W Müller; R D Granstein
Journal:  J Invest Dermatol       Date:  1996-10       Impact factor: 8.551

5.  Role of UVB-induced serum factor(s) in suppression of contact hypersensitivity in mice.

Authors:  R P Swartz
Journal:  J Invest Dermatol       Date:  1984-10       Impact factor: 8.551

6.  Regulation of contact hypersensitivity by interleukin 10.

Authors:  T A Ferguson; P Dube; T S Griffith
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

Review 7.  The dual role of IL-10.

Authors:  Simone Mocellin; Monica C Panelli; Ena Wang; Dirk Nagorsen; Francesco M Marincola
Journal:  Trends Immunol       Date:  2003-01       Impact factor: 16.687

8.  A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis.

Authors:  H Groux; A O'Garra; M Bigler; M Rouleau; S Antonenko; J E de Vries; M G Roncarolo
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

9.  Low zone tolerance to contact allergens in mice: a functional role for CD8+ T helper type 2 cells.

Authors:  K Steinbrink; C Sorg; E Macher
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

10.  T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.

Authors:  H Xu; N A DiIulio; R L Fairchild
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307

View more
  7 in total

1.  T cell killing by tolerogenic dendritic cells protects mice from allergy.

Authors:  Ulrike Luckey; Marcus Maurer; Talkea Schmidt; Nadine Lorenz; Beate Seebach; Martin Metz; Kerstin Steinbrink
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

2.  Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response.

Authors:  Jingxue Wang; Yongmin Zhang; Jing Wei; Xiaoping Zhang; Bei Zhang; Zhenyuan Zhu; Wei Zou; Yiqin Wang; Zhirong Mou; Bin Ni; Yuzhang Wu
Journal:  Immunology       Date:  2007-03-20       Impact factor: 7.397

Review 3.  [Immunology of allergic contact dermatitis].

Authors:  A S Lonsdorf; A H Enk
Journal:  Hautarzt       Date:  2009-01       Impact factor: 0.751

4.  Low-dose tolerance is mediated by the microfold cell ligand, reovirus protein sigma1.

Authors:  Agnieszka Rynda; Massimo Maddaloni; Dagmara Mierzejewska; Javier Ochoa-Repáraz; Tomasz Maslanka; Kathryn Crist; Carol Riccardi; Beata Barszczewska; Kohtaro Fujihashi; Jerry R McGhee; David W Pascual
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

5.  Transforming growth factor-beta/Smad3 signalling regulates inflammatory responses in a murine model of contact hypersensitivity.

Authors:  M Anthoni; N Fyhrquist-Vanni; H Wolff; H Alenius; A Lauerma
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

6.  In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure.

Authors:  Flurina Meiler; Judith Zumkehr; Sven Klunker; Beate Rückert; Cezmi A Akdis; Mübeccel Akdis
Journal:  J Exp Med       Date:  2008-11-10       Impact factor: 14.307

7.  Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cells.

Authors:  Ting Liu; Jun Ren; Wei Wang; Xia-wei Wei; Guo-bo Shen; Yan-tong Liu; Min Luo; Guang-chao Xu; Bin Shao; Sen-yi Deng; Zhi-yao He; Xiao Liang; Yu Liu; Yan-Zhu Wen; Rong Xiang; Li Yang; Hong-xin Deng; Yu-quan Wei
Journal:  Sci Rep       Date:  2015-11-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.